These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33627075)

  • 21. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
    Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
    Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Line probe assay test in new cases of tuberculosis with rifampicin resistance not detected by Xpert MTB/RIF.
    Soedarsono S; Mertaniasih NM; Hasan H; Kusmiati T; Permatasari A; Kusumaningrum D; Wijaksono W
    Int J Mycobacteriol; 2022; 11(4):429-434. PubMed ID: 36510930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study.
    Jacobson KR; Barnard M; Kleinman MB; Streicher EM; Ragan EJ; White LF; Shapira O; Dolby T; Simpson J; Scott L; Stevens W; van Helden PD; Van Rie A; Warren RM
    Clin Infect Dis; 2017 Jun; 64(11):1502-1508. PubMed ID: 28199520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
    Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
    Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
    Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
    Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria.
    E Ahiarakwem II; Ekejindu IM; Akujobi CN; Aghanya IN
    Niger J Clin Pract; 2020 Aug; 23(8):1172-1177. PubMed ID: 32788498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
    Mutayoba BK; Ershova J; Lyamuya E; Hoelscher M; Heinrich N; Kilale AM; Range NS; Ngowi BJ; Ntinginya NE; Mfaume SM; Nkiligi E; Doulla B; Lyimo J; Kisonga R; Kingalu A; Lema Y; Kondo Z; Pletschette M
    Trop Med Int Health; 2022 Oct; 27(10):891-901. PubMed ID: 36089572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective Diagnostic Accuracy Study of Abbott RealTi
    Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM
    Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
    Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
    BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
    Soeroto AY; Lestari BW; Santoso P; Chaidir L; Andriyoko B; Alisjahbana B; van Crevel R; Hill PC
    PLoS One; 2019; 14(2):e0213017. PubMed ID: 30818352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran.
    Nasiri MJ; Zamani S; Pormohammad A; Feizabadi MM; Aslani HR; Amin M; Halabian R; Imani Fooladi AA
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):9-14. PubMed ID: 28823010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
    Vīksna A; Sadovska D; Berge I; Bogdanova I; Vaivode A; Freimane L; Norvaiša I; Ozere I; Ranka R
    BMC Infect Dis; 2023 Sep; 23(1):638. PubMed ID: 37770850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    Getahun M; Blumberg HM; Ameni G; Beyene D; Kempker RR
    PLoS One; 2022; 17(9):e0274426. PubMed ID: 36099255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia.
    Bedewi Omer Z; Mekonnen Y; Worku A; Zewde A; Medhin G; Mohammed T; Pieper R; Ameni G
    Int J Mycobacteriol; 2016 Dec; 5(4):475-481. PubMed ID: 27931690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
    Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
    Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.